ClinicalTrials.gg
RecruitingNCT02306382Updated Nov 29, 2023

Multicenter Study for Diagnosis and Treatment of Perianal Abscesses

An interventional study of Perianal abscess drainage and 3D ultrasonography in Perianal Abscess, Anal Fistulas and Incontinence, sponsored by University Hospital, Umeå. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-29.

Sponsored by University Hospital, Umeå · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 11 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Drainage of perianal abscesses is a well established treatment. Traditionally its been done in general anesthesia after the swelling has been localised its been drained with a knife. After surgical intervention complications can occur with recidivism, chronic fistulas that go from the anal to the skin and sometimes the anal sphincter is damaged which can cause problems with incontinence.

Through ultrasound the abscess is opened under more controlled forms with a better visual overview. This is a new technique that has not been tested in larger studies. The aim with ultrasound-drainage as with traditional incision to drain the abscess so that the infected area can heal.

The hypothesis is a reduction of recurrences and formation of fistulas with the use of 3D ultrasonography.

Read the detailed description

The individual patient is informed about the condition and if meets criteria is offered to take part in the study. Written information and informed consent always noted. Questions about the patients general medical condition is noted and if the person has had problems with perianal abscesses before.

02

Conditions studied

  • Perianal Abscess
  • Anal Fistulas
  • Incontinence

Keywords

  • endoanal ultrasonography
  • drainage
  • perianal abscess
  • fistulas
  • incontience
03

In context

Rectal Fistula

169 studies on the registry are indexed under Rectal Fistula; 45 are open to participants now.

This study's planned enrollment of 200 is above the median of 66 across 115 interventional studies indexed under Rectal Fistula.

Browse Rectal Fistula studies →

Lead sponsor

University Hospital, Umeå is the lead sponsor of 6 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • perianal abscess that needs surgical treatment, over the age of 18

Exclusion criteria

Exclusion Criteria:

  • Under the age of 18 or unable to understand study information because of language difficulties or dementia.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    ultrasonography, abscess

    The experimental group will be treated after examination with 3D ultrasonography. Follow up after two months and one year.

    Procedure: Perianal abscess drainage · Device: 3D ultrasonography

  • Other
    Control group with clincial inscision

    The control group will have drainage of their perianal abscess in the OR without ultrasound. Follow-up after two months and one year.

    Procedure: Perianal abscess drainage

Interventions

  • ProcedurePerianal abscess drainage

    The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.

    Also known as: 1

  • Device3D ultrasonography

    The patientens will be randomly selected and after they have taken part and said yes to the study, half the group will undergo examination with ultrasound and half without. After this random selection all the patients abscess will be drained.

    Also known as: 2

06

What researchers measure

Primary outcomes

  1. adverse events

    Patients will be assessed in the outpatient clinic after 2 months and 1 year after surgical treatment. Eventual complications may include anal sepsis, recurrence of anal abscess and fistula formation.

    Time frame: up to one year

07

Study locations

1 of 1 sites recruiting
  • Department of Surgery
    Umea, County Of Vasterbotten § 901 85, Sweden
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2012, a primary completion of Dec 2025 and a completion of Dec 2028. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 13, 2012
First posted
Dec 3, 2014
Start
Dec 2012
Primary completionEst.
Dec 2025
CompletionEst.
Dec 2028
Last update
Nov 29, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 29, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02306382
Lead sponsor
University Hospital, Umeå
Responsible party
Karin Gustafsson (MD, University Hospital, Umeå) — Principal investigator
First posted
Dec 3, 2014
Start date
Dec 2012
Primary completion
Dec 2025 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 29, 2023

Study contacts

Karin Strigård, MD
Contact
karin.strigard@surgery.umu.se
+46 785 5000
Ulf Gunnarsson, MD
Contact
ulf.gunnarsson@ki.se
+46 8 5177 0000
Karin Gustafsson, MD
principal investigator · University Hospital, Umeå
Karin Strigård Strigård, MD
study director · University Hospital, Umeå
Ulf Gunnarsson, MD
study chair · University Hospital, Umeå

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion